Anthrax and supplements
This article was originally published in The Tan Sheet
Executive Summary
FDA issues brief caution against supplements indicated for anthrax prevention, treatment in statement posted on CFSAN Web site Nov. 7. "At this time, there is no credible scientific evidence to suggest that dietary supplements on the market will prevent or treat anthrax," agency says. "Consult your physician at once if you believe you need to be treated for anthrax." Statement directs parties to FTC "consumer alert" for more information (1"The Tan Sheet" Nov. 5, p. 3). AHPA, CHPA, CRN, NNFA, UNPA reinforce similar message in Nov. 5 joint declaration...
You may also be interested in...
FDA, FTC, 30 State AGs Join Forces To Combat Fraudulent Anthrax Products
The Federal Trade Commission is renewing efforts to track down colloidal silver supplements sold online under a federal and state multi-agency campaign against fraudulent products indicated for anthrax
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.